Effects of metformin on weight loss after sleeve gastrectomy: a single-center, randomized, controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023912

Enrollment

Unknown

Registered

2019-06-18

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and diabetes

Interventions

Metformin:Take metformin after surgery

Observation group:control

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 16-65 years; 2. BMI > 32.5; 3. The course of T2DM is 10 years, and there is still some insulin secretion function in the islet, and the fasting serum c-peptide is 1/2 of the lower limit of normal value.

Exclusion criteria

Exclusion criteria: 1. Drug or alcohol abuse or mental illness that is difficult to control; 2. Failure to cooperate with postoperative changes in diet and living habits, poor compliance; 3. Poor general condition, difficult to tolerate general anesthesia or surgery.

Design outcomes

Primary

Measure	Time frame
weight;blood pressure;blood glucose;	—

Secondary

Measure	Time frame
Blood lipid level;	—

Countries

China

Contacts

Public ContactShaozhuang Liu

Qilu Hospital, Shandong University

liushaozhuang@sdu.edu.cn+86 18560085165

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026